FDA Gives Verdict On Regenerect
A big shout out to James Douglas, a poster on the Repspace.com forums for contributing this awesome piece of information. For those of you keeping up with the Regenerect saga, and for those of you who hadn't heard of Regenerect, its a product that was released by a company called Regeneca. Regeneca is a health and wellness mlm company that began marketing Regenerect as an all natural erectile booster. The product was very expensive, and came labeled as not containing any unnatural ingredients, such as the vital components that make prescription pills such as Viagra effective. After the product was launched, it was proven to be very effective in doing what it said it did, causing a major stir all over the mlm and direct selling industry. Along with the direct effect of better erections, people were also experiencing blood pressure spikes, severe headaches, lightheadedness and other similar symptoms. To put it in perspective, if you are one of the many unlucky candidates who don't have the right kind of ticker to handle Viagra, then the stuff potentially kill you. In short, Regenerect was released as an all natural "supplement" that promised it was safe for everyone. Naturally, anyone who observed the product and wasn't found fit for Viagra thought they found a healthy alternative and jumped on it. As it turns out, Regenerect was found to contain the drug Sildenafil, which is the active pharmaceutical ingredient in Viagra, and an FDA-approved drug used for the treatment of erectile dysfunction. To the best of my knowledge, no one was harmed or suffered any fatal effects from this scam, but the fact remains that it leaves a somewhat silent, significant change to the mlm world in general, because we once had to worry about losing money, but now we need to consider our lives, and those of our clients, should we be involved with a direct selling company.. Below is a link to a letter written by the FDA in regard to its decision about Regenerect. (Link provided by James Douglas).
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm256982.htm